About US
Contact us
-
The pressure's on Novo's marketing force as FDA nod for liraglutide nearsNovo Nordisk ($NVO) may be nearing the regulatory finish line with an obesity-fighting dose of liraglutide, up for debate by the FDA's advisers this week. But as its struggling rivals can attest, when2014/9/10
-
Judge: Merck must fight claims that it lied about mumps vaccine benefitsMerck ($MRK) tried to block two lawsuits claiming it lied about the efficacy of its mumps vaccine--but the pharma giant couldn't stop them. A federal judge in Pennsylvania refused to dismiss the lawsu2014/9/9
-
The top 10 best-selling multiple sclerosis drugs of 2013Want a surefire way to shake up a drug market? Introduce new medication options that make it easier for patients to manage their disease. MS drugmakers would know; their market is all of a sudden full2014/9/5
-
FDA clears sNDA for UCB’s Vimpat anti-epileptic drug as monotherapyThe US Food and Drug Administration (FDA) has cleared a supplemental new drug application (sNDA) for UCB's Vimpat (lacosamide) C-V as montherapy to treat partial-onset seizures in patients with epilep2014/9/4
-
Indian Excipients Industry Partner to Set Up IPEC IndiaIndia's leading names in pharmaceutical excipients are joining forces to set up its first ever excipients council. The founding members of IPEC India are Mr Ajit Singh of ACG Worldwide and Mr Subodh2014/9/4
-
FDA clears GSK’s Promacta sNDA to treat SAA patientsThe US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with severe aplastic2014/9/3
-
Pfizer and Protalix’s Elelyso receives FDA approval to treat type 1 Gaucher diseasePfizer and Protalix BioTherapeutics have secured approval from the US Food and Drug Administration (FDA) for Elelyso (taliglucerase alfa) to treat paediatric patients with type 1 Gaucher disease. Ele2014/9/2
-
UK Government to provide additional £160m to Cancer Drugs FundThe UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients. The funding is intended to increase the grant from £200m a year t2014/9/1
-
Administrative Measures for Medical Device Registration and other four Administrative Measures issuedThe newly revised Regulations for the Supervision and Administration of Medical Devices was put into force on June 1, 2014. To support the implementation of the Regulations, China Food and Drug Admini2014/8/29
-
Novartis CEO Jimenez shrugs off biosimilars in the short termSwiss drugmaker Novartis ($NVS) last month became the first drugmaker to present the FDA with an application for abiosimilar, kicking off a new era in the U.S. that many believe will be a game changer2014/8/28